Premenstrual depression predicts future major depressive disorder.

Area of Science:

• Psychiatry
• Reproductive Health
• Epidemiology

Background:

• Premenstrual changes are increasingly recognized as potential indicators of mental health risks.
• Major depressive disorder (MDD) is a significant public health concern with complex etiology.
• Identifying early risk factors for MDD is crucial for timely intervention.

Purpose of the Study:

• To evaluate the predictive power of premenstrual symptom severity for the development of future major depressive disorder (MDD).
• To determine if premenstrual changes serve as an independent risk factor for MDD.
• To compare the predictive utility of retrospective assessment versus prospective daily ratings.

Main Methods:

• A follow-up study involving 36 women who participated in prior menstrual cycle research.
• Utilized the depressive subscale of the Premenstrual Assessment Form (PAF) for initial evaluation.
• Employed multiple regression analysis to assess predictive value against known MDD risk factors.

Main Results:

• Premenstrual Assessment Form (PAF) scores showed a significant correlation (r = 0.35) with the subsequent occurrence of major depressive disorder (MDD).
• PAF scores provided predictive value for MDD risk independently of family history and personal history of depression.
• The Premenstrual Change Index did not significantly enhance the predictive power of the PAF score.

Conclusions:

• Retrospective assessment of premenstrual depression using instruments like the PAF is a valid method for identifying women at risk of developing future major depressive disorder (MDD).
• Premenstrual symptom assessment offers valuable insights into future mental health trajectories.
• Further research can explore integrating prospective and retrospective measures for comprehensive risk assessment.